Walker Daniel, Lancaster Lorna, James Richard, Kleanthous Colin
Department of Biology, University of York, York YO10 5YW, UK.
Protein Sci. 2004 Jun;13(6):1603-11. doi: 10.1110/ps.04658504. Epub 2004 May 7.
Colicin E3 is a cytotoxic ribonuclease that specifically cleaves 16S rRNA at the ribosomal A-site to abolish protein synthesis in sensitive Escherichia coli cells. We have performed extensive mutagenesis of the 96-residue colicin E3 cytotoxic domain (E3 rRNase), assayed mutant colicins for in vivo cytotoxicity, and tested the corresponding E3 rRNase domains for their ability to inactivate ribosome function in vitro. From 21 alanine mutants, we identified five positions where mutation resulted in a colicin with no measurable cytotoxicity (Y52, D55, H58, E62, and Y64) and four positions (R40, R42, E60, and R90) where mutation caused a significant reduction in cytotoxicity. Mutations that were found to have large in vivo and in vitro effects were tested for structural integrity through circular dichroism and fluorescence spectroscopy using purified rRNase domains. Our data indicate that H58 and E62 likely act as the acid-base pair during catalysis with other residues likely involved in transition state stabilization. Both the Y52 and Y64 mutants were found to be highly destabilized and this is the likely origin of the loss of their cytotoxicity. The identification of important active site residues and sequence alignments of known rRNase homologs has allowed us to identify other proteins containing the putative rRNase active site motif. Proteins that contained this active site motif included three hemagglutinin-type adhesins and we speculate that these have evolved to deliver a cytotoxic rRNase into eukaryotic cells during pathogenesis.
大肠杆菌素E3是一种细胞毒性核糖核酸酶,它在核糖体A位点特异性切割16S rRNA,从而在敏感的大肠杆菌细胞中消除蛋白质合成。我们对96个氨基酸的大肠杆菌素E3细胞毒性结构域(E3核糖核酸酶)进行了广泛的诱变,检测突变型大肠杆菌素的体内细胞毒性,并测试相应的E3核糖核酸酶结构域在体外使核糖体功能失活的能力。从21个丙氨酸突变体中,我们确定了5个突变导致大肠杆菌素无明显细胞毒性的位置(Y52、D55、H58、E62和Y64)以及4个突变导致细胞毒性显著降低的位置(R40、R42、E60和R90)。通过使用纯化的核糖核酸酶结构域进行圆二色性和荧光光谱分析,对在体内和体外有较大影响的突变进行了结构完整性测试。我们的数据表明,H58和E62可能在催化过程中作为酸碱对,其他残基可能参与过渡态稳定。发现Y52和Y64突变体都高度不稳定,这可能是它们细胞毒性丧失的原因。重要活性位点残基的鉴定以及已知核糖核酸酶同源物的序列比对,使我们能够鉴定出其他含有假定核糖核酸酶活性位点基序的蛋白质。含有该活性位点基序的蛋白质包括三种血凝素型黏附素,我们推测这些黏附素在发病过程中进化为将细胞毒性核糖核酸酶传递到真核细胞中。